Malabsorption Syndrome Market Size, Competitive Landscape, and Revenue Forecast Through 2034

The increasing prevalence of gastrointestinal (GI) disorders significantly drives the market. According to the World Gastroenterology Organisation, disorders such as celiac disease, Crohn’s disease, and irritable bowel syndrome (IBS) are on the rise globally. A study paper titled “Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis 2017” discovered that celiac disease impacts approximately 1.4% of the worldwide population.